Crossmark

The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis

Crossref DOI link: https://doi.org/10.1186/s13099-024-00616-w

Published Online: 2024-05-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuu, Elizabeth Y.

Bührer, Christoph

Eckmanns, Tim

Fulde, Marcus

Herz, Michaela

Kurzai, Oliver

Lindstedt, Christin

Panagiotou, Gianni

Piro, Vitor C.

Radonic, Aleksandar

Renard, Bernhard Y.

Reuss, Annicka

Siliceo, Sara Leal

Thielemann, Nadja

Thürmer, Andrea

Vorst, Kira van

Wieler, Lothar H.

Haller, Sebastian
Funding

Funding for this research was provided by:

HORIZON EUROPE Marie Sklodowska-Curie Actions (H2020-MSCA-ITN-2018)

Innovative Training Networks (813781 “BestTreat”)

Bundesministerium für Bildung und Forschung (Project NeoBIOM - 03ZZ0829A)

Robert Koch-Institut
License Information

Text and Data Mining valid from 2024-05-12

Version of Record valid from 2024-05-12
More Information

Article History

Received: 13 September 2023

Accepted: 13 April 2024

First Online: 12 May 2024

Declarations

:

: This study was approved by the Ethics Commttee of Charité in Berlin, Germany (Number EA2/134/17) approved on 10.08.2017 The animal study protocol was approved by the Tierschutzgesetz (Animal Welfare Act §8 section 1; 19.06.2018).

: Informed consent was obtained by parents/guardians from all subjects involved in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below